ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mäkitaro, R.
Right arrow Articles by Kinnula, V.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mäkitaro, R.
Right arrow Articles by Kinnula, V.L.
Eur Respir J 2002; 19:1087-1092
Copyright ©ERS Journals Ltd 2002


Prospective population-based study on the survival of patients with lung cancer

R. Mäkitaro1, P. Pääkko2, E. Huhti1, R. Bloigu3 and V.L. Kinnula1

Depts of 1 Internal Medicine, 2 Pathology and3 Medical Faculty, University of Oulu, and Oulu University Hospital, Oulu, Finland

CORRESPONDENCE: R. Mäkitaro, Dept of Internal Medicine, Oulu University Hospital, Kajaanintie 50, FIN-90220, Oulu, Finland. Fax: 358 83154139. E-mail: riitta.makitaro@oulu.fi

Keywords: lung cancer, population-based study, survival

Received: May 29, 2000
Accepted December 5, 2001

This research was supported by the Finnish Anti-Tuberculosis Association Foundation and the Cancer Society of North Finland.

The purpose of this study was to evaluate the change, over 20 yrs, in the survival of lung cancer patients in a population-based study.

Information on all patients with lung cancer in a defined geographical area during 1990–1992 (n=602) was prospectively gathered. The survival of these patients was assessed and also compared with the results of a similar study in the same area during the years 1968–1971 (n=446).

The 5-yr survival had improved during 20 yrs from 4% to 12%. The 5-yr survival of the patients with squamous cell carcinoma had increased from 6% to 16%, and adenocarcinoma from 4% to 19%, whereas the survival of small cell carcinoma had remained the same (2% and 3%, respectively). Even though the recent patients were older than those of the earlier series the proportion of surgically treated patients had remained the same (16% and 20%), but the 5-yr survival of patients who had been operated on had increased significantly from 23% to 48%. The differences in survival in the second cohort (1990–1992) between histological types (Chi-squared logrank=59.2), tumour, node, metastasis stages (Chi-squared logrank=199.6), symptomatic stages (Chi-squared logrank=120, p<0.001) and treatment (Chi-squared logrank=277) were significant.

Based on this study the independent prognostic factors for better survival of lung cancer patients are tumour, node, metastasis stages I and II, surgical treatment and Feinstein's symptomatic stages I and II.




This article has been cited by other articles:


Home page
ThoraxHome page
M Thirumaran, R Sundar, I M Sutcliffe, and D C Currie
Is investigation of patients with haemoptysis and normal chest radiograph justified?
Thorax, October 1, 2009; 64(10): 854 - 856.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the European Respiratory Society.